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Acetylcysteine and enzymatic creatinine: beware of laboratory artefact!
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Sir: N-Acetylcysteine (NAC) is an antioxidant agent used as a mucolytic and to prevent acute hepatic failure following paracetamol poisoning [1]. NAC has also been thought to prevent radiocontrast nephrotoxicity [2]. Potential analytical interferences between NAC and creatinine measurement have been poorly studied. Tepel et al. showed no interference between their Jaffé creatinine and NAC in vitro [2]. Enzymatic methods are more precise and specific for creatinine measurement than the classic Jaffe methods [3]. Enzymatic assays are thus recommended. However, creatinine enzymatic assays are not free from interference, as has been described with flucytosine and high doses of dobutamine [3].
We have studied, in vitro, potential interferences between NAC and creatinine measurement by Jaffe and enzymatic methods. We decided to study three serum pools with creatinine concentrations around 1, 2 and 4.5mg/dl. Each sample was analysed in duplicate before and directly after adding increasing doses of NAC from 500 to 10,000 µg/ml (ampoule at a concentration of 100,000 µg/ml), using both the Jaffe method (CREA Jaffé; Roche Modular, Mannheim, Germany) and the enzymatic method (CREA Plus; Roche Modular, Mannheim, Germany). Volumes of the samples were adjusted to avoid dilution interference. Interference was considered as significant when the difference between the values measured before and after NAC addition was over 10% [4]. We performed the experiment in triplicate. The mean creatinine values of pools were thus 1.01 ± 0.24 mg/dl, 2.14 ± 0.07 mg/dl and 4.83 ± 0.49 mg/dl.
According to our criterion, we did not observe any interference with the Jaffe method. However, significant interferences were found when the enzymatic method was used from an acetylcysteine concentration of 1,000 µg/ml upward. The interferences increased with acetylcysteine concentrations (mean differences for the three pools went from -3.7% for an acetylcysteine concentration of 500 µg/ml to 71.7% for an acetylcysteine concentration of 10,000 µg/ml) (Table 1). In the three pools of creatinine, we observed a strict linear decrease in creatinine values with increasing doses of NAC (between 500 and 7,500 µg/ml) (r = 0.99).







Table 1: Interference of N-acetylcysteine (NAC) in enzymatic creatinine measurements (expressed in mg/dl)
Concentration of NAC added in vitro (µg/ml)	Three pools around 1 mg/dl (mean: 1.01 mg/dl): mean differences in % from base-line concentrations (standard deviation)	Three pools around 2 mg/dl (mean: 2.14 mg/dl): mean differences in % from base-line concentrations (standard deviation)	Three pools around 4.5 mg/dl (mean: 4.83 mg/dl): mean differences in % from base-line concentrations (standard deviation)
500	-3.9% (±1.1%)	-4.7% (± 0.8%)	-2.4% (±1.1%)
1,000	-ll.l%(±2.1%)a	-9.6% (± 1.7%)	-7.5% (±1.2%)
5,000	-44.8%(±11.9%)a	-51.6%(±8.2%)a	-50% (± 11.4%)a
7,500	-63.6% (± 15.9%)a	-62.4% (± 10.7%)a	-62.6% (± 10.2%)a
10,000	-70.7(±11.2%)a	-70.3% (± 6.3%)a	-74.1%(±5.8%)a
aDifference over 10%, viewed as clinically significant
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